evaluating-strategic-alternatives

name	evaluating-strategic-alternatives
description	Structures strategic alternatives analysis with status quo, sale, merger, spin-off, and recapitalization scenario comparison. Use when evaluating strategic options, preparing board-level alternatives, or analyzing corporate transformations.
tags	["analysis","capital-allocation-and-corporate-strategy"]
metadata	{"author":"casemark","practice_areas":["Corporate Strategy","Capital Allocation","Shareholder Value"],"document_types":["Evaluation Report"],"skill_modes":["Analysis","Assessment"]}

Evaluating Strategic Alternatives

Structures a rigorous comparison of strategic paths — status quo, full sale, merger, spin-off/carve-out, and recapitalization — so boards and management teams can make informed capital allocation decisions with quantified trade-offs.

When To Use

• Board or special committee is formally evaluating whether to sell, merge, restructure, or stay the course
• Management is preparing a strategic alternatives presentation for the board or an activist response
• Financial advisor needs a framework to compare disparate transaction structures on common metrics
• Company faces a hostile bid, unsolicited offer, or shareholder pressure demanding a review of options
• Pre-process planning before launching a formal sale or dual-track process

Inputs To Gather

• Company financials: 3–5 years of historical income statement, balance sheet, and cash flow; current LTM figures; management projections (base, upside, downside)
• Capital structure: Outstanding debt (terms, covenants, change-of-control provisions), equity capitalization, convertible instruments, option pool
• Valuation anchors: Recent trading multiples, precedent transaction comps, analyst price targets, prior indication-of-interest (IOI) values if any
• Tax and structural data: Net operating losses, tax basis of assets, entity structure, jurisdictional considerations [VERIFY: confirm NOL utilization limits and Section 382 applicability]
• Stakeholder constraints: Board fiduciary mandates, shareholder agreements, golden parachute / change-of-control triggers, regulatory approval requirements [VERIFY: Hart-Scott-Rodino thresholds, industry-specific approvals such as FCC, state insurance, banking regulators]
• Strategic context: Competitive dynamics, customer/supplier concentration, IP or licensing dependencies, integration complexity factors

Workflow

1. Establish the status quo baseline

   • Build a standalone DCF using management projections; sensitize on revenue growth, margin trajectory, and WACC
   • Derive an implied share price range under status quo and compare to current trading price
   • Identify key operating risks that threaten the standalone plan (market share loss, margin compression, capex needs)

2. Define each alternative scenario

   • Full sale (100% acquisition): Model at a range of acquisition premiums (15–45% typical); estimate net proceeds to shareholders after fees, taxes, and debt payoff
   • Merger / merger-of-equals: Estimate synergy value (cost and revenue), allocate synergy credit, model exchange ratio range, assess pro forma ownership dilution and EPS accretion/dilution
   • Spin-off / carve-out: Identify separable business unit; estimate standalone EBITDA, stranded costs, and dis-synergies; model public-market re-rating of each entity post-separation
   • Recapitalization: Model leveraged recap (special dividend or share buyback funded by new debt); stress-test against cash flow to ensure covenant compliance through cycle; calculate per-share value return versus go-forward equity value

3. Build the comparison matrix

   • Align all scenarios on common metrics: implied value per share (range), time to value realization, execution risk (high/medium/low), tax leakage, regulatory complexity, and stakeholder impact
   • Score execution risk by considering: number of required approvals, antitrust exposure, financing conditionality, integration difficulty, market-timing sensitivity

4. Run sensitivity and scenario analysis

   • For each alternative, test bear / base / bull assumptions on the two or three variables with the most valuation impact
   • Identify crossover points where one alternative becomes dominant (e.g., "sale is superior if offer exceeds $X; recap is superior if EBITDA stays above $Y")

5. Assess fiduciary and process considerations

   • Flag whether a formal market check, go-shop, or fairness opinion is advisable [VERIFY: state corporate law requirements — Revlon duties, Unocal standard if applicable]
   • Note any lock-up, break-fee, or matching-right implications
   • Document conflicts of interest among management, directors, or significant shareholders

6. Synthesize recommendation

   • Present a clear rank-ordering of alternatives with supporting rationale

Output

The deliverable is a Strategic Alternatives Evaluation Report containing:

• Executive summary: One-page recommendation with the top two or three alternatives and the rationale for the preferred path
• Status quo valuation: DCF range, trading comps, key standalone risks
• Scenario detail pages: One section per alternative with valuation range, key assumptions, and execution risk assessment
• Comparison matrix: Side-by-side table of all alternatives across value, risk, timing, tax, and stakeholder dimensions
• Sensitivity tables: Tornado or data-table format showing how the ranking shifts under stress assumptions
• Process roadmap: Recommended next steps, indicative timeline, advisor roles, and board milestones

Quality Checks

• Every valuation range must tie back to clearly stated assumptions — no unexplained point estimates
• Confirm that the status quo baseline uses the same projection set as the transaction scenarios (apples-to-apples)
• Verify that tax treatment reflects actual entity structure, not simplified assumptions [VERIFY]
• Ensure change-of-control provisions in debt agreements and executive contracts are reflected in net proceeds calculations
• Check that synergy estimates in merger scenarios are sourced (management, advisor benchmarks, or precedent deals) and not assumed
• Confirm regulatory approval timelines are realistic based on the specific agencies involved [VERIFY]
• Flag any scenario where management has a conflicting economic incentive (e.g., higher payout under sale but job continuity under status quo)
• Validate that the comparison matrix uses consistent discount rates and terminal assumptions across all scenarios